PERSPECTA

News from every angle

Back to headlines

Personalized mRNA cancer vaccine shows promising results in melanoma study

A personalized mRNA cancer vaccine has demonstrated promising results in a phase 3 study, showing effectiveness in preventing the recurrence or spread of melanoma after surgery.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.